Randomized controlled GH trial: Effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome

Clinical Endocrinology

Volumn 69, Issue 3, 2008, Pages 443-451

  Festen, Dederieke A M ^a   De Lind Van Wijngaarden, Roderick ^a   Van Eekelen, Marielle ^a   Otten, Barto J ^b   Wit, Jan M ^c   Duivenvoorden, Hugo J ^d   Hokken Koelega, Anita C S ^a,e  

^a Dutch Growth Research Foundation   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; HUMAN GROWTH HORMONE; SOMATOMEDIN C;

ADOLESCENT; ANTHROPOMETRY; ARTICLE; BEDTIME DOSAGE; BODY COMPOSITION; BODY FAT; BODY GROWTH; BODY MASS; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HEAD CIRCUMFERENCE; HUMAN; INFANT; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; PRADER WILLI SYNDROME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ALGORITHMS; ANTHROPOMETRY; BODY COMPOSITION; BODY HEIGHT; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INFANT; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; MALE; PRADER-WILLI SYNDROME;

EID: 49649094042     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2008.03228.x     Document Type: Article

References (34)

1. Nicholls, R.D. (1993) Genomic imprinting and uniparental disomy in Angelman and Prader-Willi syndrome. American Journal of Medical Genetics, 46, 16 25.
2. Buiting, K., Saitoh, S. Gross, S. (1995) Inherited microdeletions in the Angelman and Prader-Willi syndromes define an imprinting centre on human chromosome 15. Nature Genetics, 9, 395 400.
3. Swaab, D.F. (1997) Prader-Willi and the hypothalamus. Acta Paediatrica Supplement, 423, 50 54.
4. Burman, P., Ritzen, E.M. Lindgren, A.C. (2001) Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH. Endocrine Reviews, 22, 787 799.
5. Lee, P.D.K., Wilson, D.M., Rountree, L., Hintz, R.L. Rosenfeld, R.G. (1987) Linear growth response to exogenous growth hormone in Prader-Willi syndrome. American Journal of Medical Genetics, 28, 865 871.
6. Angulo, M., Castro-Magana, M., Mazur, B., Canas, J., Vitollo, P. Sarrantonio, M. (1996) Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader-Willi syndrome. Journal of Pediatric Endocrinology and Metabolism, 9, 393 400.
7. Lindgren, A.C., Hagenas, L., Muller, J., Blichfeldt, S., Rosenborg, M., Trismar, T. Ritzen, E.M. (1998) Growth hormone treatment of children with Prader-Willi syndrome affects linear growth and body composition favourably. Acta Paediatrica, 87, 28 31.
8. Carrel, A.L., Myers, S.E., Whitman, B.Y. Allen, D.B. (1999) Growth hormone improves body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome: a controlled study. Journal of Pediatrics, 134, 215 221.
9. Hauffa, B.P. (1997) One-year results of growth hormone treatment of short stature in Prader-Willi syndrome. Acta Paediatrica, 423, 63 65.
10. Craig, M.E., Cowell, C.T., Larsson, P., Zipf, W.B., Reiter, E.O., Albertsson Wikland, K., Ranke, M.B. Price, D.A. (2006) Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database). Clinical Endocrinology, 65, 178 185.
11. Myers, S.E., Carrel, A.L., Whitman, B.Y. Allen, D.B. (2000) Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome. Journal of Pediatrics, 137, 42 49.
12. Myers, S.E., Whitman, B.Y., Carrel, A.L., Moerchen, V., Bekx, M.T. Allen, D.B. (2007) Two years of growth hormone therapy in young children with Prader-Willi syndrome: physical and neurodevelopmental benefits. American Journal of Medical Genetics Part A, 143A, 433 448.
13. Tanner, J.M. Whitehouse, R. (1976) Longitudinal standards for height, weight-height, height velocity and stages of puberty. Archives of Diseases in Childhood, 51, 170 179.
14. Cameron, N. (1978) The methods of auxological anthropometry. In : F. Falkner, J. Tanner eds. Human Growth: Postnatal Growth. Tindall, London, 35 90.
15. Fredriks, A., van Buuren, S. Burgmeijer, R. (2000) Continuing positive secular growth change in the Netherlands 1955-97. Pediatric Research, 47, 316 323.
16. Fredriks, A., van Buuren, S. Wit, J. (2000) Body index measurements in 1996-7 compared with 1980. Archives of Diseases in Childhood, 82, 107 112.
17. Boot, A., Bouquet, J., de Ridder, M., Krenning, E. de Muinck Keizer-Schrama, S. (1997) Determinants of body composition measured by dual-energy X-ray absorptiometry in Dutch children and adolescents. American Journal of Clinical Nutrition, 66, 232 238.
18. Hokken-Koelega, A., Hackeng, W., Stijnen, T., Wit, J., de Muinck-Keizer-Schrama, S. Drop, S. (1990) Twenty-four hour plasma growth hormone (GH) profiles, urinary excretion, and plasma insulin-like growth factor-I and II levels in pre-pubertal children with chronic renal insufficiency and severe growth retardation. Journal of Clinical Endocrinology and Metabolism, 71, 688 695.
19. Festen, D.A.M., de Weerd, A.W., van den Bossche, R.A.S., Joosten, K., Hoeve, H. Hokken-Koelega, A.C.S. (2006) Sleep-related breathing disorders in prepubertal children with Prader-Willi syndrome and effects of growth hormone treatment. Journal of Clinical Endocrinology and Metabolism, 91, 4911 4915.
20. Festen, D.A.M., van Toorenenbergen, A., Duivenvoorden, H.J. Hokken-Koelega, A.C.S. (2007) Adiponectin levels in pre-pubertal children with Prader-Willi syndrome before and during growth hormone therapy. Journal of Clinical Endocrinology and Metabolism, 92, 1549 1554.
21. Festen, D.A.M., Visser, T.J., Otten, B.J., Wit, J.M., Duivenvoorden, H.J. Hokken-Koelega, A.C.S. (2007) Thyroid hormone levels in children with Prader-Willi syndrome before and during growth hormone treatment. Clinical Endocrinology, 67, 449 456.
22. Eiholzer, U., Gisin, R., Weinmann, C., Kriemler, S., Steinert, H., Torresani, T., Zachmann, M. Prader, A. (1998) Treatment with human growth hormone in patients with Prader-Labhart-Willi syndrome reduces body fat and increases muscle mass and physical performance. European Journal of Pediatrics, 157, 368 377.
23. Loche, S., Cappa, M., Borrelli, P., Faedda, A., Crino, A., Cella, S.G., Corda, R., Muller, E.E. Pintor, C. (1987) Reduced growth hormone-releasing hormone in children with simple obesity: evidence for somatomedin-C mediated inhibition. Clinical Endocrinology, 27, 145 153.
24. Radetti, G., Bozzola, M., Pasquino, B., Paganini, C., Aglialoro, A., Livieri, C. Barreca, A. (1998) Growth hormone bioactivity, insulin-like growth factors (IGFs), and IGF binding proteins in obese children. Metabolism, 47, 1490 1493.
25. Aughton, D.J. Cassidy, S.B. (1990) Physical features of Prader-Willi syndrome in neonates. American Journal of Diseases in Childhood, 144, 1251 1254.
26. Eiholzer, U. l'Allemand, D. (2000) Growth hormone normalises height, prediction of final height and hand length in children with Prader-Willi syndrome after 4 years of therapy. Hormone Research, 53, 185 192.
27. Lindgren, A.C. Ritzen, E.M. (1999) Five years of growth hormone treatment in children with Prader-Willi syndrome. Swedish National Growth Hormone Advisory Group. Acta Paediatrica 88 (suppl 109 111.
28. Brambilla, P., Bosio, L., Manzoni, P., Pietrobello, A., Beccaria, L. Chiumello, G. (1997) Peculiar body composition in patients with Prader-Labhart-Willi syndrome. American Journal of Clinical Nutrition, 65, 634 642.
29. Eiholzer, U., l'Allemand, D., van der Sluis, I., Steinert, H., Gasser, T. Ellis, K. (2000) Body composition abnormalities in children with Prader-Willi syndrome and long-term effects of growth hormone therapy. Hormone Research, 53, 200 206.
30. Jones, J.I. Clemmons, D.R. (1995) Insulin-like growth factors and their binding proteins: biological actions. Endocrine Reviews, 16, 3 34.
31. Juul, A., Holm, K., Kastrup, K.W., Pedersen, S.A., Michaelsen, K.F., Scheike, T., Rasmussen, S., Muller, J. Skakkebaek, N.E. (1997) Free insulin-like growth factor I serum levels in 1430 healthy children and adults, and its diagnositic value in patients suspected of growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism, 82, 2497 2502.
32. Carrel, A.L., Moerchen, V., Myers, S.E., Bekx, T., Whitman, B.Y. Allen, D.B. (2004) Growth hormone improves mobility and body composition in infants and toddlers with Prader-Willi Syndrome. Journal of Pediatrics, 145, 744 749.
33. Lanes, R. Jakubowicz, S. (2002) Is insulin-like growth factor-I monitoring useful in assessing the response to growth hormone of growth-hormone deficient children? Journal of Pediatrics, 141, 606 610.
34. Carrel, A.L., Myers, S.E., Whitman, B.Y. Allen, D.B. (2002) Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study. Journal of Clinical Endocrinology and Metabolism, 87, 1581 1585.